Azd 5582

Manufactured by Active Motif

AZD-5582 is a small molecule compound used in laboratory research. It functions as an agonist for the glucocorticoid receptor. The core function of AZD-5582 is to activate and stimulate the glucocorticoid receptor, which plays a role in various cellular processes.

Automatically generated - may contain errors

Lab products found in correlation

At 406, by Active Motif (2 mentions) Gdc 0917, by Active Motif (2 mentions) High molecular weight poly 1 c, by InvivoGen (2 mentions) Lcl161, by Novartis (2 mentions) Ifn β, by PBL Assay Science (1 mentions) Tnf α, by Enzo Life Sciences (1 mentions) On targetplus smartpool, by Horizon Discovery (1 mentions) Vp 16, by Merck Group (1 mentions) On targetplus smartpool, by Thermo Fisher Scientific (1 mentions) Tumor necrosis factor (tnf), by Enzo Life Sciences (1 mentions) Cycloheximide (chx), by Merck Group (1 mentions) Staurosporine, by Merck Group (1 mentions)

2 protocols using azd 5582

Apoptosis Induction Pathway Analysis

Cited 1 time

Check if the same lab product or an alternative is used in the 5 most similar protocols

Novartis provided LCL161 (ref. 44 (link)). Tetralogic Pharmaceuticals provided Birinapant48 (link). AT-406, GDC-0917 and AZD-5582 were purchased from Active Biochem. TNF-α was purchased from Enzo. IFN-β was obtained from PBL Assay Science. Broad host range IFN-αB/D was produced in yeast and purified by affinity immunochromatography24 (link). Nontargeting siRNA or siRNA targeting cFLIP were obtained from Dharmacon (ON-TARGETplus SMARTpool). High molecular weight poly(I:C) was obtained from Invivogen.

Beug S.T., Beauregard C.E., Healy C., Sanda T., St-Jean M., Chabot J., Walker D.E., Mohan A., Earl N., Lun X., Senger D.L., Robbins S.M., Staeheli P., Forsyth P.A., Alain T., LaCasse E.C, & Korneluk R.G. (2017). Smac mimetics synergize with immune checkpoint inhibitors to promote tumour immunity against glioblastoma. Nature Communications, 8, 14278.

+ Open protocol

+ Expand

Apoptosis Induction Reagent Procurement

Check if the same lab product or an alternative is used in the 5 most similar protocols

Novartis provided LCL161 (18) . SM-164 was provided by S. Wang (University of Michigan, USA) (54) . Birinapant was obtained from Tetralogic Pharmaceuticals (55) . OICR720 was synthesized by the Ontario Institute for Cancer Research (OICR) (56) . AT-406, GDC-0917, and AZD-5582 were purchased from Active Biochem. TNF- was purchased from Enzo. IFN- was obtained from PBL Assay Science. All siRNAs were obtained from Dharmacon (ON-TARGETplus SMARTpool) or Ambion (Silencer Select for IFR1). High-molecular weight poly(I:C) was obtained from InvivoGen. VP16, staurosporine, and cycloheximide were obtained from Sigma.

Beug S.T., Cheung H.H., Sanda T., St-Jean M., Beauregard C.E., Mamady H., Baird S.D., LaCasse E.C, & Korneluk R.G. (2019). The transcription factor SP3 drives TNF-α expression in response to Smac mimetics. Science signaling, 12(566).

+ Open protocol

+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Revolutionizing how scientists
search and build protocols!